Cargando…
Neues zur Therapie von Lebermalignomen
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807005/ http://dx.doi.org/10.1007/s15004-022-8949-y |
| _version_ | 1784643593628024832 |
|---|---|
| author | Hartmann, Daniel Martignoni, Marc |
| author_facet | Hartmann, Daniel Martignoni, Marc |
| author_sort | Hartmann, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8807005 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88070052022-02-02 Neues zur Therapie von Lebermalignomen Hartmann, Daniel Martignoni, Marc InFo Hämatol Onkol Editorial Springer Medizin 2022-02-02 2022 /pmc/articles/PMC8807005/ http://dx.doi.org/10.1007/s15004-022-8949-y Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Editorial Hartmann, Daniel Martignoni, Marc Neues zur Therapie von Lebermalignomen |
| title | Neues zur Therapie von Lebermalignomen |
| title_full | Neues zur Therapie von Lebermalignomen |
| title_fullStr | Neues zur Therapie von Lebermalignomen |
| title_full_unstemmed | Neues zur Therapie von Lebermalignomen |
| title_short | Neues zur Therapie von Lebermalignomen |
| title_sort | neues zur therapie von lebermalignomen |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807005/ http://dx.doi.org/10.1007/s15004-022-8949-y |
| work_keys_str_mv | AT hartmanndaniel neueszurtherapievonlebermalignomen AT martignonimarc neueszurtherapievonlebermalignomen |